Nootropic profile
Vinconate
A vinca alkaloid derivative related to vinpocetine that enhances cerebral blood flow through phosphodiesterase inhibition and calcium channel blocking, marketed in Japan for cerebrovascular disorders.
Best for
Educational only: this is not medical advice. Always check with a qualified healthcare professional before starting any supplement.
What is Vinconate?
Vinconate (ethyl apovincaminate analogue) is a semi-synthetic vinca alkaloid derivative structurally and pharmacologically related to vinpocetine, both being derived from the periwinkle plant (Vinca minor) alkaloid vincamine.
What it does for you
Community and editorial ratings, out of 5:
How to take it
- Standard clinical dose: 15-30 mg taken two to three times daily (total daily dose of 30-90 mg) as used in Japanese clinical practice
- Starting dose: 15 mg twice daily, with gradual titration based on clinical response and tolerability
- Duration of treatment: Treatment courses of 8-12 weeks are typical in clinical trials, with many patients receiving long-term maintenance therapy for...
- Administration: Oral tablets taken after meals to improve absorption and reduce gastrointestinal side effects
- Availability: Available primarily in Japan through prescription; not approved by the FDA or EMA and generally unavailable through Western supplement or...
Watch out for
- Generally well-tolerated: Japanese post-marketing surveillance has shown a favourable safety profile, with adverse effects typically being mild and transient
- Gastrointestinal effects: The most commonly reported side effects include nausea, abdominal discomfort, and loss of appetite, usually mild and self-limiting
- Hypotensive effects: Although cerebrovascular selectivity minimises systemic blood pressure effects, some patients may experience mild dizziness or...
- Antiplatelet interaction: Due to its antiplatelet activity, caution is warranted in patients taking anticoagulants (warfarin, heparin) or other antiplatelet...
- Hepatic metabolism: Metabolised primarily by the liver; patients with significant hepatic impairment may require dose adjustment or more careful monitoring
The science, if you're curious.
- Inhibits PDE1 in cerebral vascular smooth muscle, elevating intracellular cGMP and cAMP levels, leading to smooth muscle relaxation and cerebral...
- Blocks voltage-gated calcium channels in both vascular smooth muscle and neurons, contributing to vasodilation and providing neuroprotection against...
- Enhances the efficiency of aerobic glucose metabolism in neurons and glial cells, improving ATP production and supporting the energy demands of cognitive...
- Increases red blood cell deformability, allowing them to pass more easily through narrow cerebral capillaries and improving oxygen delivery to brain tissue...
Where to find it
- Ishihara et al. (1989): Study on Vinconate's effects on cerebral blood flow and metabolism published in the Journal of Cerebral Blood Flow and Metabolism, demonstrating cerebrovascular selectivity
- Japanese pharmaceutical product information: Official prescribing information for Vinconate tablets as approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)
- Vinca alkaloid review: Vas and Bhatt (2008) - comprehensive review of vinca alkaloid derivatives including vincamine, vinpocetine, and Vinconate for cerebrovascular and cognitive applications
- PDE inhibitor pharmacology: Bender and Bhatt (2006) - "Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use" in Pharmacological Reviews, covering PDE1 inhibitors including vinca alkaloid derivatives
- Cerebrovascular pharmacotherapy: Hagiwara et al. (1984) - "Pharmacological profile of Vinconate" in Japanese Journal of Pharmacology, providing comprehensive preclinical characterisation
Frequently asked
A vinca alkaloid derivative related to vinpocetine that enhances cerebral blood flow through phosphodiesterase inhibition and calcium channel blocking, marketed in Japan for cerebrovascular disorders.
The main benefits people report from Vinconate are: Cognitive Enhancement, Energy, Focus, Longevity, Memory, Mood.
Standard clinical dose: 15-30 mg taken two to three times daily (total daily dose of 30-90 mg) as used in Japanese clinical practiceStarting dose: 15 mg twice daily, with gradual titration based on clinical response and tolerabilityDuration of treatment: Treatment courses of 8-12 weeks are typical i...
Generally well-tolerated: Japanese post-marketing surveillance has shown a favourable safety profile, with adverse effects typically being mild and transientGastrointestinal effects: The most commonly reported side effects include nausea, abdominal discomfort, and loss of appetite, usually mild and...
Inhibits PDE1 in cerebral vascular smooth muscle, elevating intracellular cGMP and cAMP levels, leading to smooth muscle relaxation and cerebral...Blocks voltage-gated calcium channels in both vascular smooth muscle and neurons, contributing to vasodilation and providing neuroprotection against...En...
Rate Vinconate
Log in to leave an overall rating.
What people are saying
Log in to leave a comment.
No comments yet. Be the first to share your experience.